Kupando

Kupando is a pioneering biopharmaceutical company developing TLR 4/7 agonists that stimulate innate immunity for use in oncology and infectious diseases.
Kupando is a private company, seed financed by its CEO Johanna Holldack and based on technology invented by Dennis Carson’s Laboratory at the University of California San Diego.
The Company’s management team brings a unique wealth of experience in business and drug development, gained in the US and Europe.
Kupando is headquartered in Schoenefeld, Germany.